17 April 2012
WesternU Dean to publish Alzheimer’s research
Pomona, CA – Michel Baudry, PhD, dean of the Graduate College of Biomedical Sciences at Western University of Health Sciences, will publish his research on the critical role of oxidative stress in Alzheimer’s disease and a potential treatment.
10 April 2012
Antioxidant May Disrupt Alzheimer's Disease Process
Amsterdam, NL – Alzheimer’s disease (AD) is now the sixth leading cause of death among Americans, affecting nearly 1 in 8 people over the age of 65. There is currently no treatment that alters the course of this disease.
6 April 2012
Pulse Pressure Elevation Could Presage Cerebrovascular Disease in Alzheimer’s Patients
Researchers at the University of California, San Diego and Veterans Affairs San Diego Healthcare System have shown that elevated pulse pressure may increase the risk of cerebrovascular disease (CVD) in older adults with Alzheimer’s disease (AD).
30 March 2012
Amyloid beta in the brain of individuals with Alzheimer’s disease
The deposition of amyloid beta in the brain of individuals with Alzheimer’s disease is the focus of much research into both its cause and treatment.
28 March 2012
MRI and neuropsychological tests best predict Alzheimer’s disease in old patients
Amsterdam, NL – Investigators from the University of Amsterdam, Netherlands, have shown that in most elderly patients invasive and expensive techniques, i.e. lumbar puncture and PET scan, are not useful to establish the diagnosis of Alzheimer’s disease.
26 March 2012
Role of Amyloid Beta as Sensors and Protectors in Alzheimer’s and Other Diseases Explored
Amsterdam, NL – Alzheimer’s disease is the sixth leading cause of death in the United States and the only cause of death among the top 10 in America without a way to prevent, cure or even slow its progression, according to the Alzheimer’s Association.
26 March 2012
Variability in blood-based amyloid-ß assays: The need for consensus on pre-analytical processing
Associate Professor Kevin Barnham from the Mental Health Research Institute has recently finished a report that highlights both the need for standard blood collection and processing methods in Alzheimer’s disease research, and a way forward.
23 March 2012
A new test might facilitate diagnosis and drug development for Alzheimer’s disease
An international team of researchers have developed a new method for measurement of aggregated beta-amyloid – a protein complex believed to cause major nerve cell damage and dysfunction in Alzheimer’s disease.
23 March 2012
Brain atrophy can predict further cognitive decline in Alzheimer’s disease
Researchers from the Alzheimer Center, VU University Medical Center in Amsterdam, the Netherlands, have found a way to predict clinical progression of Alzheimer’s disease in subjects in the predementia stage.
Pages
